Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Accurate cardiac output assessment is crucial for evaluating hemodynamic status and guiding therapeutic interventions. The fourth generation FloTrac software (the FloTrac method) provides minimally invasive, continuous, and real-time cardiac output estimations. This study aimed to evaluate the accuracy, precision, and trending performance of cardiac output measurements using the FloTrac method compared to bolus thermodilution cardiac output derived from a pulmonary artery catheter (the thermodilution method).

Methods: This prospective clinical interventional study included 41 cardiac surgery patients from September 2023 to September 2024 at Aarhus University Hospital, Denmark. Cardiac output was measured simultaneously using both the FloTrac method and thermodilution method, before and after two preload-increasing interventions: a modified Trendelenburg maneuver and a fluid bolus administration. Bias, limits of agreement, and percentage error between the methods were assessed for each time point. Trending ability was evaluated using four-quadrant plots and concordance rates. Interchangeability of the two methods was accepted with a bias within the range of ±0.5 L/min, PE < 30%, and concordance rates ≥ 90%.

Results: Bias ranged from -0.36 to 0.79 L/min depending on the intervention, with consistently wide limits of agreement. Percentage errors were 37% and 35% before and after fluid administration, and 37% and 42% before and after the Trendelenburg maneuver. The concordance rate was 85% after fluid administration and 72% after the modified Trendelenburg maneuver. The FloTrac method identified fluid responders with a sensitivity of 23% and specificity of 84% with the thermodilution method as reference.

Conclusion: The FloTrac method did not meet the criteria for interchangeability with the thermodilution method for measuring cardiac output in patients after cardiac surgery. Percentage errors were unacceptable for all time points.

Editorial Comment: This study assessed an updated version of the FlowTrac cardiac output estimation system, comparing results in clinical cases with some modest preload variation to same time cardiac output measurement with pulmonary artery-based thermodilution measurements. The findings showed that there was limited agreement between these two methods in these settings, suggesting that they do not appear to be interchangeable.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12193115PMC
http://dx.doi.org/10.1111/aas.70077DOI Listing

Publication Analysis

Top Keywords

cardiac output
24
flotrac method
12
fourth generation
8
generation flotrac
8
flotrac software
8
cardiac
7
output
6
flotrac
5
method
5
software pulse
4

Similar Publications

Objective: This study evaluates cardiac function in older adults with T2DM and preserved LVEF using two-dimensional speckle-tracking echocardiography to explore the risk factors associated with subclinical left ventricular systolic dysfunction (GLS <18%) in this population.

Methods: All patients (n = 87, aged 60 years and above) and controls (n = 20) underwent clinical assessment and echocardiography, including GLS assessment.

Results: Univariate analysis identified gender (OR 3.

View Article and Find Full Text PDF

Harlequin syndrome, also known as differential hypoxia (DH) or North-South syndrome, is a serious complication of femoro-femoral venoarterial extracorporeal membrane oxygenation (V-A ECMO). Moreover, Harlequin syndrome is caused by competing flows between the retrograde oxygenated ECMO output and the anterograde ejection of poorly oxygenated blood from the native heart. In the setting of impaired pulmonary gas exchange, the addition of an Impella device (ECPELLA configuration), although beneficial for ventricular unloading and hemodynamic support, may further exacerbate this competition and precipitate DH.

View Article and Find Full Text PDF

Purpose: Spinal anesthesia-induced hypotension can cause detrimental effects on both the mother and the fetus, and it remains a significant concern in obstetric anesthesia. The use of vasopressors is considered the most reliable and effective approach. Previous studies have shown that norepinephrine appears to be superior to phenylephrine in maintaining maternal heart rate and cardiac output.

View Article and Find Full Text PDF

Optimized FDA Blood Pump: A Case Study in System-Level Customized Ventricular Assist Device Designs.

Ann Biomed Eng

September 2025

Department of Mechanical Engineering, Koc University, Rumeli Feneri Campus, Sarıyer, 34450, Istanbul, Turkey.

Purpose: The design and development of ventricular assist devices have heavily relied on computational tools, particularly computational fluid dynamics (CFD), since the early 2000s. However, traditional CFD-based optimization requires costly trial-and-error approaches involving multiple design cycles. This study aims to propose a more efficient VAD design and optimization framework that overcomes these limitations.

View Article and Find Full Text PDF

Background: Fetal growth restriction (FGR) causes an adaptive redistribution of the cardiac output towards sustained cerebral vasodilation. However, the consequences of FGR and cerebral vasodilatation due to fetal hypoxia on the blood-brain barrier (BBB) are still poorly studied. This study assesses BBB permeability in the neonatal cortex of pups gestated under intrauterine hypobaric hypoxia.

View Article and Find Full Text PDF